Taxotere Lawsuit

Taxotere is an additive used in chemotherapy to treat breast and other forms of cancer. Studies are linking permanent hair loss, known as alopecia, and thinning hair to the use of Taxotere. Those affected are moving forward with a Taxotere Lawsuit against the drug manufacturer.

Taxotere Lawsuit Alleges Permanent Hair Loss Misreported

As a result of permanent hair loss, many women have filed a Taxotere lawsuit against the manufacturer, Sanofi-Aventis, alleging that the company knew that permanent hair loss related to Taxotere use occurred at a higher rate than it claimed, and instead of informing patients and the medical community, the company attempted to downplay that side effect in the interest of profits.

Hair loss can have a major effect on a woman’s mental health. According to a 2004 study on the importance of hair conducted at Arizona State University, hair “is personal, growing directly out of our bodies. It is public, on view for all to see. And it is malleable, allowing us to change it more or less at whim. As a result, it’s not surprising that we use our hair to project our identity and that others see our hair as a reflection of our identity.” Said another way, when women lose their hair, they lose a part of their identity, and every aspect of their lives may be affected.

Instant Case Decision

See if you qualify for a Taxotere Lawsuit and the right to potentially significant financial recovery.

The Taxotere Instant Case Evaluator provides lawsuit qualification information and details regarding your situation.

  1. Did you or a loved one undergo chemotherapy in the past?
  2. Does hair loss or thinning hair remain today?
View Your Taxotere Case Report

What is Taxotere?

Taxotere (generic name docetaxel) is an anti-cancer chemotherapy drug manufactured by Sanofi.  It is used in the treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate cancer. It is a drug that is given intravenously (IV) and works by slowing cell growth. Taxotere is generally given over 1 hour every 3 weeks, or as directed by a doctor.

Permanent hair loss or thinning hair after chemotherapy?
Get Instant Online Analysis Now!

Alopecia Could Have Been Avoided

Most women would likely not have chosen to be treated with Taxotere had they known:

  • The risk of permanent hair loss associated with the medication.
  • There are other chemotherapy drug options, such as Taxol, that do not result in permanent hair loss.

Taxotere Lawsuit Frequently Asked Questions

TruLaw uses the Taxotere Instant Case Evaluator as a tool to help you understand your legal rights.   We hope you find the Instant Case Evaluator to be helpful in your determination of whether a lawsuit is right for you.

If TruLaw determines you qualify for our Taxotere lawsuit, you will be sent an electronic contract. We will not be able to move forward in legally representing you until this contract is signed.

Please call us if you would prefer a hard copy of the contract.

Very basically, there are two parts to the taxotere lawsuit – Injury and Use. Taxotere lawsuits are being filed on behalf of individuals who have experienced permanent hair loss (permanent alopecia). If you underwent chemotherapy treatments and you are experiencing incomplete hair regrowth 6 months after chemotherapy, your injury may qualify for this lawsuit.

Secondly, this lawsuit is being filed against Sanofi for their product, Taxotere. Taxotere was used in the majority of chemotherapy treatments prior to 2011, after 2011, we will need to verify the use of Taxotere via medical records.

To check your qualification report for your situation, fill out our Taxotere Instant Case Evaluation form to view your report online now.

Nothing unless/until we are successful in your lawsuit.

No, the lawsuits that we are filing are against the manufacturer of the drug, Sanofi.   The Taxotere lawsuits allege that Sanofi was aware of the risk of permanent hair loss and did not warn the public or medical professionals.   When manufacturers of drugs such as Taxotere do not give the public full information about their drugs, there is no way to make an informed decision, and they should be held accountable when injuries occur.

Taxotere is given via IV in your physician’s office or clinic, therefore it is unlikely you are aware if you were given Taxotere. Until Taxotere went generic in November 2011, Taxotere was used in the majority of chemotherapy treatments.

Since the drug went generic, there are many other versions of the drug that could have been used. The medication used during your chemotherapy treatment will be indicated in your medical records. You may want to contact your doctor’s office or clinic to gather this information, or we will assist you in gathering this information.